BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Stem cell
,
Holistic medicine
,
Doxorubicin
,
rs2300478
,
PPARA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PARP
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
B lymphocyte (IgM memory) of spleen
B lymphocyte (naive) of spleen
Plasma cell of spleen
Tonsil
Olfactory bulb
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Xeroderma pigmentosum
Sepsis due to Streptococcus agalactiae
Systemic infection
Sepsis due to Gram negative bacteria
Smoker
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Aminoglutethimide
5-(6)-carboxyfluorescein diacetate succinimidyl ester
Ethylene Glycol
Dipyrone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir129
Zfp281
EZR
PARP1
FOSL2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
PARP1 Promotes Heart Regeneration and Cardiomyocyte Proliferation.
The role of PARP1 in neurodegenerative diseases and aging.
NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis.
Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative s…
PARP1-catalyzed PARylation of YY1 mediates endoplasmic reticulum stress in granulosa cells to determ…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer
PD1 and PARP for Maintenance Therapy in NSLLC
Effect of PARP Inhibitors on Glomerular Filtration Rate
PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locall…
PET Imaging of PARP Activity in Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ